149 related articles for article (PubMed ID: 18388038)
1. Effects of policosanol (10 mg/d) versus aspirin (100 mg/d) in patients with intermittent claudication: a 10-week, randomized, comparative study.
Illnait J; Castaño G; Alvarez E; Fernández L; Mas R; Mendoza S; Gamez R
Angiology; 2008; 59(3):269-77. PubMed ID: 18388038
[TBL] [Abstract][Full Text] [Related]
2. Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.
Castaño G; Más R; Gámez R; Fernández L; Illnait J
Angiology; 2004; 55(4):361-71. PubMed ID: 15258682
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication.
Castaño G; Más R; Roca J; Fernández L; Illnait J; Fernández JC; Selman E
Angiology; 1999 Feb; 50(2):123-30. PubMed ID: 10063942
[TBL] [Abstract][Full Text] [Related]
4. A long-term study of policosanol in the treatment of intermittent claudication.
Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C
Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084
[TBL] [Abstract][Full Text] [Related]
5. Effects of policosanol and lovastatin in patients with intermittent claudication: a double-blind comparative pilot study.
Castaño G; Más R; Fernández L; Gámez R; Illnait J
Angiology; 2003 Jan; 54(1):25-38. PubMed ID: 12593493
[TBL] [Abstract][Full Text] [Related]
6. Concomitant use of policosanol and beta-blockers in older patients.
Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
[TBL] [Abstract][Full Text] [Related]
7. Effect of policosanol on platelet aggregation in type II hypercholesterolemic patients.
Arruzazabala ML; Más R; Molina V; Carbajal D; Mendoza S; Fernández L; Valdés S
Int J Tissue React; 1998; 20(4):119-24. PubMed ID: 10093795
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of policosanol Versus acipimox in patients with type II hypercholesterolemia.
Alcocer L; Fernández L; Campos E; Más R
Int J Tissue React; 1999; 21(3):85-92. PubMed ID: 10645516
[TBL] [Abstract][Full Text] [Related]
9. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.
Gresele P; Migliacci R; Procacci A; De Monte P; Bonizzoni E
Thromb Haemost; 2007 Mar; 97(3):444-50. PubMed ID: 17334512
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of iloprost in patients with intermittent claudication.
Creager MA; Pande RL; Hiatt WR
Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
[TBL] [Abstract][Full Text] [Related]
11. Combined aspirin and cilostazol treatment is associated with reduced platelet aggregation and prevention of exercise-induced platelet activation.
Cleanthis M; Bhattacharya V; Smout J; Ashour H; Stansby G
Eur J Vasc Endovasc Surg; 2009 May; 37(5):604-10. PubMed ID: 19297212
[TBL] [Abstract][Full Text] [Related]
12. Long-term therapy with policosanol improves treadmill exercise-ECG testing performance of coronary heart disease patients.
Stüsser R; Batista J; Padrón R; Sosa F; Pereztol O
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):469-73. PubMed ID: 9760006
[TBL] [Abstract][Full Text] [Related]
13. A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication.
Collins P; Ford I; Ball D; Macaulay E; Greaves M; Brittenden J
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):266-73. PubMed ID: 16360327
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication.
Treat-Jacobson D; Bronas UG; Leon AS
Vasc Med; 2009 Aug; 14(3):203-13. PubMed ID: 19651669
[TBL] [Abstract][Full Text] [Related]
15. Treadmill exercise in claudicants on aspirin results in improved antioxidant status but only minimal platelet activation.
Cleanthis M; Smout J; Bhattacharya V; Ashour H; Shenton B; Stansby G
Platelets; 2005 Dec; 16(8):446-52. PubMed ID: 16287611
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
[TBL] [Abstract][Full Text] [Related]
17. Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudication.
Gresele P; Migliacci R; Arosio E; Bonizzoni E; Minuz P; Violi F;
J Vasc Surg; 2012 Dec; 56(6):1622-8, 1628.e1-5. PubMed ID: 22963812
[TBL] [Abstract][Full Text] [Related]
18. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
[TBL] [Abstract][Full Text] [Related]
19. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
[TBL] [Abstract][Full Text] [Related]
20. Effects of policosanol on patients with ischemic stroke: a pilot open study.
Ortega LL; Sánchez J; Más R; Fernández L; Mendoza S; Gámez R; Fernández JC; Illnait J; Alvarez E
J Med Food; 2006; 9(3):378-85. PubMed ID: 17004902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
